Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Income from Continuing Operations (2020 - 2025)

Rani Therapeutics Holdings has reported Income from Continuing Operations over the past 6 years, most recently at 8498000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 8498000.0 for Q4 2025, up 45.95% from a year ago — trailing twelve months through Dec 2025 was 40374000.0 (up 28.65% YoY), and the annual figure for FY2025 was 40374000.0, up 28.65%.
  • Income from Continuing Operations for Q4 2025 was 8498000.0 at Rani Therapeutics Holdings, down from 7914000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for RANI hit a ceiling of 5485000.0 in Q2 2021 and a floor of 28700000.0 in Q3 2021.
  • Median Income from Continuing Operations over the past 5 years was 13941500.0 (2022), compared with a mean of 14065200.0.
  • Biggest five-year swings in Income from Continuing Operations: crashed 895.49% in 2021 and later surged 45.95% in 2025.
  • Rani Therapeutics Holdings' Income from Continuing Operations stood at 13305000.0 in 2021, then crashed by 30.57% to 17372000.0 in 2022, then rose by 19.09% to 14055000.0 in 2023, then decreased by 11.86% to 15722000.0 in 2024, then surged by 45.95% to 8498000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 8498000.0 (Q4 2025), 7914000.0 (Q3 2025), and 11224000.0 (Q2 2025) per Business Quant data.